Skip to main content

ORTHOFIX International N V Value Stock - Dividend - Research Selection

Orthofix international n v

ISIN: US68752M1080 , WKN: A2NB0X

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Orthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Orthofix Medical Wins 'Best Patient Experience Solution' Award in 2024 MedTech Breakthrough Awards Program

2024-05-17
Texas - Orthofix Medical Inc. , a leading global spine and orthopedics company, today announced that it has been selected as winner of the 'Best Patient Experience Solution' award in the 8th annual...

JMP Securities Reaffirms Their Hold Rating on Orthofix (OFIX)

2024-05-17
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program

2024-05-16
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 16, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced that Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, has been selected as winner of

Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance

2024-05-13
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.

Orthofix gets FDA clearance for Rodeo Telescopic Nail

2024-05-09
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail

2024-05-09
LEWISVILLE, Texas, May 09, 2024--The Rodeo nail is designed to address the biomechanical and procedural challenges associated with implanting in the fragile bone associated with OI.

Orthofix receives FDA clearance to market Rodeo Telescopic Nail

2024-05-09
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript

2024-05-08
Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript May 7, 2024 Orthofix Medical Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $-0.32. OFIX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]

Roth MKM ups Orthofix to buy, cites improving fundamentals

2024-05-08
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday

2024-05-08
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.